A double-blind placebo-controlled study found that elderly people with hearing loss can triple their understanding of words in noisy situations by training on a custom audiomotor game.
Boston, Mass. — For many people with hearing challenges, trying to follow a conversation in a crowded restaurant or other noisy venue is a major struggle, even with hearing aids. Now, Mass. Eye and Ear researchers reporting in Current Biology on October 19th have some good news: time spent playing a specially designed, brain-training audiogame could help.
In fact, after playing the game, hearing impaired elderly people correctly made out 25 percent more words in the presence of high levels of background noise. The training provided about three times more benefit than hearing aids alone.
“These findings underscore that understanding speech in noisy listening conditions is a whole brain activity, and is not strictly governed by the ear,” said Daniel B. Polley, Ph.D., Director of the Lauer Tinnitus Research Center of Massachusetts Eye and Ear and associate professor of otolaryngology at Harvard Medical School. “The improvements in speech intelligibility following closed loop audiomotor perceptual training did not arise from an improved signal being transferred from the ear to the brain. Our subjects’ hearing, strictly speaking, did not get better.” And, yet, their ability to make sense of what they’d heard did.
Those improvements reflect better use of other cognitive resources, including selective auditory attention, Polley explained. In other words, participants were better able to filter out noise and distinguish between a target speaker and background distractions.
The study enrolled 24 older adults, at an average of 70-years-old. All participants had mild to severe hearing loss and had worn hearing aids for an average of 7 years. Participants were randomly assigned to one of two training groups. Members of both groups were asked to spend 3.5 hours per week for 8 weeks playing a game. One group played a game designed with the intention of improving player’s ability to follow conversations. It challenged them to monitor subtle deviations between predicted and actual auditory feedback as they moved their fingertip through a virtual soundscape. As a “placebo” control, the other group played a game that challenged player’s auditory working memory and wasn’t expected to help with speech intelligibility.
The study was designed so that the 24 participants and the researchers did not know who trained with the audiogame programmed for therapeutic benefit and who trained with a “placebo” game without therapeutic intent. Participants from each group reported equivalent expectations that their speech understanding would be improved.
People in both groups improved on their respective auditory tasks and had comparable expectations for improved speech processing. Despite those expectations, individuals that played the working memory game showed no improvement in their ability to make out words or even improvements on other working memory tasks. The other group showed marked improvements, correctly identifying 25 percent more words in spoken sentences or digit sequences presented in high levels of background noise. Those gains in speech intelligibility could also be predicted based on the accuracy with which those individuals played the game.
Those benefits didn’t persist in the absence of continuing practice, the researchers report. However, they say, the findings show that “perceptual learning on a computerized audiogame can transfer to ‘real world’ communication challenges.” Polley envisions a time when hearing challenges might be managed through a combination of auditory training software coupled with the latest in-ear listening devices.
“We look forward to a future where auditory perceptual training software that has been inspired by principles of brain plasticity, not audiological testing, is packaged with new advances in these listening devices,” he said. “There is reason to believe that the sum of these benefits would be greater than could be expected from any one approach applied in isolation.”
In addition to Dr. Polley, authors on the Current Biology report include lead author Jonathon P. Whitton, Au.D., Ph.D., and Kenneth E. Hancock., Ph.D., of Massachusetts Eye and Ear/Harvard Medical School, and Jeffrey M. Shannon., Au.D., of the Hudson Valley Audiology Center. The research was supported by National Institutes of Health grant no. P50DC015857 and a research grant from the One Fund Boston.
Please note that, at this time, the audiogame described in the Current Biology report is confidential, to maintain double-blind study design for future experiments. Those interested in taking part future studies may reach out to HearingRehab@meei.harvard.edu to learn more about upcoming trials.
About Massachusetts Eye and Ear
Mass. Eye and Ear clinicians and scientists are driven by a mission to find cures for blindness, deafness and diseases of the head and neck. Now united with Schepens Eye Research Institute, Mass. Eye and Ear is the world's largest vision and hearing research center, developing new treatments and cures through discovery and innovation. Mass. Eye and Ear is a Harvard Medical School teaching hospital and trains future medical leaders in ophthalmology and otolaryngology, through residency as well as clinical and research fellowships. Internationally acclaimed since its founding in 1824, Mass. Eye and Ear employs full-time, board-certified physicians who offer high-quality and affordable specialty care that ranges from the routine to the very complex. In the 2017–2018 “Best Hospitals Survey,” U.S. News & World Report ranked Mass. Eye and Ear #2 in the nation ear, nose and throat care and #4 for eye care. For more information about life-changing care and research, or to learn how you can help, please visit MassEyeAndEar.org.
About Current Biology
Current Biology (@CurrentBiology), published by Cell Press, is a bimonthly journal that features papers across all areas of biology. Current Biology strives to foster communication across fields of biology, both by publishing important findings of general interest and through highly accessible front matter for non-specialists. Visit: http://www.cell.com/current-biology. To receive Cell Press media alerts, contact email@example.com.